Health
Jonathan Wall receives $1.79 million to develop new amyloidosis treatment – EurekAlert
The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science…
IMAGE: Dr. Jonathan Wall
view more
Credit: UTHSC
Memphis, Tenn. (March 16, 2021) – The National Institute of Diabetes and Digestive and Kidney Diseases recently awarded Jonathan Wall, PhD, professor in the University of Tennessee Health Science Center’s Graduate School of Medicine in Knoxville, a $1.79 million grant for his study titled “Developing a Theranostic Immunotherapy for Systemic Amyloidosis.”
Amyloidosis is a rare disease that occurs when abnormal protein aggregates (called amyloid)…
-
General17 hours agoByford rail extension opening marks final stage of Perth Metronet
-
Noosa News23 hours agoFatal traffic crash, Baringa – Sunshine Coast
-
General18 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Noosa News14 hours agoSerious traffic crash, Noosa – Sunshine Coast